Join the RediTrex group to help and get support from people like you.
RediTrex News
Methotrexate Noninferior to Prednisone in Pulmonary Sarcoidosis
TUESDAY, May 20, 2025 – For patients with pulmonary sarcoidosis, methotrexate is noninferior to prednisone with regard to the change from baseline to week 24 in the percentage of the predicted...
Glucarpidase Improves Outcomes in Patients With Methotrexate-Induced Kidney Toxicity
THURSDAY, Jan. 16, 2025 – For patients with methotrexate (MTX)-acute kidney injury (AKI), glucarpidase is associated with improved renal and extrarenal outcomes, according to a study published...
Methotrexate Beneficial for Reducing Pain, Stiffness in Knee Osteoarthritis
WEDNESDAY, July 31, 2024 – For patients with knee osteoarthritis (KOA), methotrexate added to usual medication is associated with a significant reduction in pain and improvement in stiffness and...
FDA Approves RediTrex (methotrexate) for Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Psoriasis
NASHVILLE, Tenn., Dec. 2, 2019 /PRNewswire/ – Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced that it has received approval from the U.S. Food and...
Further information
Related condition support groups
Rheumatoid Arthritis, Psoriasis